CELLECT BIOTECHNOLOGY LTD's ticker is APOP and the CUSIP is 15116C102. A total of 7 filers reported holding CELLECT BIOTECHNOLOGY LTD in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $124,000 | -42.1% | 243,563 | +15.0% | 0.16% | +51.5% |
Q1 2019 | $214,000 | +154.8% | 211,854 | +429.2% | 0.10% | +472.2% |
Q4 2018 | $84,000 | -79.6% | 40,032 | -53.7% | 0.02% | -66.0% |
Q3 2018 | $412,000 | -48.4% | 86,517 | -22.4% | 0.05% | -56.9% |
Q2 2018 | $798,000 | -74.4% | 111,540 | -77.1% | 0.12% | -33.9% |
Q1 2018 | $3,114,000 | +1659.3% | 487,960 | +750.9% | 0.19% | +1760.0% |
Q4 2016 | $177,000 | -33.0% | 57,348 | 0.0% | 0.01% | 0.0% |
Q3 2016 | $264,000 | – | 57,348 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 111,540 | $798,000 | 0.12% |
American Portfolios Advisors | 1,000 | $7,150 | 0.00% |
CIBC Private Wealth Group, LLC | 50 | $0 | 0.00% |
CITIGROUP INC | 9,740 | $70,000 | 0.00% |
MORGAN STANLEY | 16,869 | $121,000 | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 61,429 | $439,000 | 0.00% |
UBS Group AG | 1,520 | $11,000 | 0.00% |